Risk factors for COVID-19 mortality: The effect of convalescent plasma administration

BACKGROUND: Convalescent plasma, widely utilized in viral infections that induce neutralizing antibodies, has been proposed for COVID-19, and preliminary evidence shows that it might have beneficial effect. Our objective was to determine the risk factors for 28-days mortality in patients who receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Salazar, Martín R., González, Soledad E., Regairaz, Lorena, Ferrando, Noelia S., González Martínez, Verónica V., Carrera Ramos, Patricia M., Muñoz, Laura, Pesci, Santiago A., Vidal, Juan M., Kreplak, Nicolás, Estenssoro, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084206/
https://www.ncbi.nlm.nih.gov/pubmed/33914780
http://dx.doi.org/10.1371/journal.pone.0250386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084206/
https://www.ncbi.nlm.nih.gov/pubmed/33914780
http://dx.doi.org/10.1371/journal.pone.0250386

Ejemplares similares